Abstract: The present invention relates to stable pharmaceutical compositions comprising one or more HMG-CoA reductase inhibitors, processes for preparing the stable compositions and uses for the compositions. The stable pharmaceutical compositions of the invention may be used, in particular, for the treatment of hyperlipoproteinemia and atherosclerosis.

Abstract: A charging system comprises an accessory module and a charging system. The accessory module includes a housing with a coupling portion and a power source. The coupling portion includes an engagement surface and a coupler configured to removably couple the accessory module to a person-support apparatus. The power source is positioned within the housing and includes a recharging assembly. The charging station includes a docking portion configured to receive the accessory module and a charging assembly configured to communicate power to the recharging assembly.

Abstract: A charging system comprises an accessory module and a charging system. The accessory module includes a housing with a coupling portion and a power source. The coupling portion includes an engagement surface and a coupler configured to removably couple the accessory module to a person-support apparatus. The power source is positioned within the housing and includes a recharging assembly. The charging station includes a docking portion configured to receive the accessory module and a charging assembly configured to communicate power to the recharging assembly.

Abstract: An apparatus comprises a housing and a communication system. The housing includes a front portion and a rear portion. The rear portion has an engagement surface and a coupler configured to cooperate with a portion of a person-support apparatus to removably couple the housing to the person-support apparatus. The communication system includes at least one communication device coupled to the housing. The communication device is configured to at least one of transmit and receive at least one of a data signal and a power signal to/from the person-support apparatus and an external device.

Abstract: A wafer processing equipment comprises a track (10) for transporting wafers, a wafer launch station (20) for launching wafers into a section of said track (10), a first wafer processing tool (30) for performing a first process to wafers in said section of said track (10), a buffer (40) for storing wafers processed by said first wafer processing tool (30), a second wafer processing tool (50) for performing a second process to wafers processed by said first wafer processing tool (30), and control means (70) for controlling said wafer launch station (20) such that every wafer launched by said launch station (20) is processed by said second processing tool (50) within a predetermined time window.